Michigan · Q0138

Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use) in Michigan

Michigan Medicare Avg
$0.39
1% below national avg
National Medicare Avg
$0.39
All states combined
Billed Charge (MI)
$2.20
What providers submit
Est. Commercial (MI)
$1.05
National avg: $1.12
Est. Cash / Self-Pay (MI)
$0.98
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

1.3M
Services in MI
72
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Michigan

Provider Medicare Services
Danish, Rizwan MD $0.39 86.7K
Kadakol, Savitha MD $0.39 77.0K
Peram, Venkatasiva M.D. $0.39 61.7K
Howard, George M.D. $0.38 58.6K
Zekman, Richard DO $0.38 55.1K
Muskovitz, Andrew M.D. $0.38 54.1K

Michigan Pricing in Context

In Michigan, CPT code Q0138 (Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use)) carries an average Medicare payment of $0.39 — 1% below the national benchmark of $0.39. 72 providers across the state submitted claims for this procedure in 2023, performing 1.3M total services. Individual payments in MI ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Michigan is $2.20, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Michigan sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Temporary Codes procedures, the estimated commercial insurance price in Michigan lands near $1.05, with self-pay cash prices typically around $0.98. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use) cost in Michigan?

The average Medicare payment for Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use) in Michigan is $0.39, which is 1% below the national average of $0.39. Providers in MI typically bill $2.20 for this procedure.

What does Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use) cost with insurance in Michigan?

With commercial insurance in Michigan, Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use) costs an estimated $1.05. Without insurance, the estimated cash price is $0.98. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use) in Michigan?

72 providers in Michigan billed Medicare for Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use) in 2023, performing 1.3M total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use) cheaper in Michigan than the national average?

Yes — Injection, Ferumoxytol, For Treatment Of Iron Deficiency Anemia, 1 Mg (non-Esrd Use) costs 1% below the national average in Michigan. The state average Medicare payment is $0.39 compared to $0.39 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial